Review ArticleReview Article
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Vincent Pons and Serge Rivest
Robert Dantzer, ASSOCIATE EDITOR, Neuroscience Laboratory, CHU de Québec Research Center and Department of Molecular Medicine, Faculty of Medicine, Laval University, 2705 Laurier Boul., Québec City, QC G1V 4G2, Canada
Pharmacological Reviews January 2022, 74 (1) 1-17; DOI: https://doi.org/10.1124/pharmrev.121.000400